Depot medroxyprogesterone acetate versus norethisterone oenanthate for long-acting progestogenic contraception : a systematic review

Simple item page
dc.contributor.advisorHoffman, Margareten_ZA
dc.contributor.authorDraper, Beverlyen_ZA
dc.date.accessioned2014-11-07T13:49:28Z
dc.date.available2014-11-07T13:49:28Z
dc.date.issued2006en_ZA
dc.descriptionIncludes bibliographical references.en_ZA
dc.description.abstract[Background] Two injectable progestogen-only contraceptives (IPCs) depot medroxyprogesterone acetate (DMPA) and norethisterone oenanthate (NET-EN) continue to be extensively used in some countries, forming a large proportion of the health system's expenditure on contraception. Both these highly effective contraceptives receive wide acceptance amongst women in their fertile years. They differ in cost and frequently of administration. A systematic comparison was undertaken to investiage their rational use. [Objectives] To determine if there are differences between depot medroxyprogesterone acetate given at a dose of 150mg IM every three months and norethisterone oenathate given at a dose of 200mg IM every two months, in terms of contraceptive effectiveness, reversibility and discontinuation patterns, and adverse clinical effects. [Study Design] A Cochrane systematic review was used to answer the question posed in the research objective. This included a systematic search for all available literature comapring DMPA and NET-EN, followed by appraisal of all studies for inclusion in the review. Meta-analysis was then applied to the included study.en_ZA
dc.identifier.apacitationDraper, B. (2006). <i>Depot medroxyprogesterone acetate versus norethisterone oenanthate for long-acting progestogenic contraception : a systematic review</i>. (Thesis). University of Cape Town ,Faculty of Health Sciences ,Department of Public Health and Family Medicine. Retrieved from http://hdl.handle.net/11427/9339en_ZA
dc.identifier.chicagocitationDraper, Beverly. <i>"Depot medroxyprogesterone acetate versus norethisterone oenanthate for long-acting progestogenic contraception : a systematic review."</i> Thesis., University of Cape Town ,Faculty of Health Sciences ,Department of Public Health and Family Medicine, 2006. http://hdl.handle.net/11427/9339en_ZA
dc.identifier.citationDraper, B. 2006. Depot medroxyprogesterone acetate versus norethisterone oenanthate for long-acting progestogenic contraception : a systematic review. University of Cape Town.en_ZA
dc.identifier.ris TY - Thesis / Dissertation AU - Draper, Beverly AB - [Background] Two injectable progestogen-only contraceptives (IPCs) depot medroxyprogesterone acetate (DMPA) and norethisterone oenanthate (NET-EN) continue to be extensively used in some countries, forming a large proportion of the health system's expenditure on contraception. Both these highly effective contraceptives receive wide acceptance amongst women in their fertile years. They differ in cost and frequently of administration. A systematic comparison was undertaken to investiage their rational use. [Objectives] To determine if there are differences between depot medroxyprogesterone acetate given at a dose of 150mg IM every three months and norethisterone oenathate given at a dose of 200mg IM every two months, in terms of contraceptive effectiveness, reversibility and discontinuation patterns, and adverse clinical effects. [Study Design] A Cochrane systematic review was used to answer the question posed in the research objective. This included a systematic search for all available literature comapring DMPA and NET-EN, followed by appraisal of all studies for inclusion in the review. Meta-analysis was then applied to the included study. DA - 2006 DB - OpenUCT DP - University of Cape Town LK - https://open.uct.ac.za PB - University of Cape Town PY - 2006 T1 - Depot medroxyprogesterone acetate versus norethisterone oenanthate for long-acting progestogenic contraception : a systematic review TI - Depot medroxyprogesterone acetate versus norethisterone oenanthate for long-acting progestogenic contraception : a systematic review UR - http://hdl.handle.net/11427/9339 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/9339
dc.identifier.vancouvercitationDraper B. Depot medroxyprogesterone acetate versus norethisterone oenanthate for long-acting progestogenic contraception : a systematic review. [Thesis]. University of Cape Town ,Faculty of Health Sciences ,Department of Public Health and Family Medicine, 2006 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/9339en_ZA
dc.language.isoengen_ZA
dc.publisher.departmentDepartment of Public Health and Family Medicineen_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.subject.otherPublic Healthen_ZA
dc.titleDepot medroxyprogesterone acetate versus norethisterone oenanthate for long-acting progestogenic contraception : a systematic reviewen_ZA
dc.typeMaster Thesis
dc.type.qualificationlevelMasters
dc.type.qualificationnameMMeden_ZA
uct.type.filetypeText
uct.type.filetypeImage
uct.type.publicationResearchen_ZA
uct.type.resourceThesisen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
thesis_hsf_2006_draper_b (1).pdf
Size:
4.22 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Masters